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BACKGROUND: Early childhood caries (ECC) is one of the most prevalent infectious 
diseases in childhood worldwide. It afflicts 23% of the preschoolers in the U.S. It most 
frequently targets children from poor socioeconomic families and racial/ethnic minority 
backgrounds and becomes a serious public health problem. The major pathogen of ECC is 
Streptococcus mutans (S. mutans). However, the occurrence of ECC is positively 
associated with the presence of Candida albicans (C. albicans).  
It is well established that Silver Diamine Fluoride (SDF), a recent Food and Drug 
Administration (FDA)-off labeled approved agent for arresting dental caries, exhibits a 
robust antibacterial effect on S. mutans associated with ECC. Very interestingly, C. 




prevalence of ECC, indicating that the reduction of C. albicans colonization in the oral 
cavity may suppress ECC. However, it remains elusive if SDF can also mediate an 
antifungal effect on C. albicans.  
OBJECTIVE: The purpose of this study was to evaluate the effect of SDF on the growth of 
C. albicans and compare it to that of fluoride varnish and fluconazole, and to determine 
the minimum inhibitory concentration (MIC) of SDF on the growth of C. albicans. 
HYPOTHESIS: We hypothesized that:  
There are significant differences in the inhibitory effect on the growth of C. albicans among 
SDF, fluoride varnish, fluconazole (positive control), and Phosphate Buffered Saline (PBS: 
negative control) groups. 
Null hypothesis: There are no significant differences in the inhibitory effect on the growth 
of C. albicans among SDF, fluoride varnish, fluconazole (positive control), and Phosphate 
Buffered Saline (PBS: negative control) groups, or SDF doesn’t possess any inhibitory 
effect of the growth of C. albicans. 
MATERIALS AND METHODS: The antifungal effect of the tested groups was determined 
using both disk diffusion assay and minimum inhibitory concentration (MIC) assay. In the 
disc diffusion assay, SDF (38%), fluoride varnish (5%), fluconazole (25 µg/mL, positive 
control) and PBS (negative control) were applied to a paper disc placed on the Mueller-
Hinton agar plate on which low concentration (invisible level) of C. albicans was evenly 
spread (1×105/plate or 1×106/plate).  After incubation at 37°C in aerobic condition for 24 





In MIC assay, the minimum inhibitory concentration of SDF (38%) and fluconazole (25 
µg/mL, positive control group) were tested by the exposure of C. albicans of 1 × 105 
concentration in a 96-well plate to the serial dilutions of the respective reagent. After 
incubation at 37°C in aerobic condition for 24 hours, the relative amount of C. albicans 
grown in the 96-well plate was measured using a plate reader and the minimum 
concentration of reagent that inhibited the growth of C. albicans was determined. 
In the disc diffusion assay, the experiment was performed in quadruplicates and repeated 
three times. A general linear model (ANOVA) followed by Tukey’s HSD test was 
employed for statistical analysis. In MIC assay, the minimum inhibitory concentration 
percentage of each material’s original concentration was calculated.  
RESULTS: SDF (38%) demonstrated a significantly higher inhibitory effect (P < .001) 
against C. albicans growth compared to fluconazole.  However, both fluoride varnish and 
PBS showed no inhibitory effect on the growth of C. albicans. 
MIC of SDF was 0.009% of its original concentration, compared to 0.6% of that for 
fluconazole, suggesting that SDF has antifungal effect even at lower concentration than 
antifungal effect mediated by fluconazole.  
CONCLUSION: This study, for the first time, demonstrated the inhibitory effect of SDF on 
the growth of C. albicans, indicating that SDF possesses antifungal property, which would 
be translated into the novel approach in arresting ECC associated with C. albicans.  
This study allows a better understanding of the SDF effect in arresting ECC and discovers 
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CHAPTER 1: INTRODUCTION 
1.1 BACKGROUND 
1.1.1 Early Childhood Caries (ECC) 
According to the American Academy of Pediatric Dentistry (AAPD), ECC is defined as 
the presence of one or more decayed (noncavitated or cavitated lesions), missing (due to 
caries), or filled tooth surfaces in any primary tooth in a child under the age of six, whereas 
severe early childhood caries (S-ECC) is defined as any sign of smooth-surface caries in a 
child younger than three years aged, and from ages three through five, one or more 
cavitated, missing (due to caries), or filled smooth surfaces in primary maxillary anterior 
teeth or a decayed, missing, or filled score of greater than or equivalent to four (age 3), 
greater than or equivalent to five (age 4), or greater than or equivalent to six (age 5) (1). 
Several terminologies were used to describe the condition and its relation to the 
inappropriate feeding practices such as nursing bottle caries, nursing caries, rampant caries, 
baby bottle caries, baby bottle tooth decay, milk bottle syndrome, and prolonged nursing 
habit caries (2). 
The child with ECC is often at higher risk of new carious lesions in both the primary and 
permanent dentition and may suffer from considerable pain, infections, and abscesses (3, 
4). If the damage extent leads to the extraction of the anterior teeth by age 2 or 3 years, the 





The pain and discomfort of ECC may lead to difficulty in eating, malnutrition, delay in 
physical development, gastrointestinal disorders, difficulty in sleeping, emergency room 
visits, loss of school days, diminished ability to learn, and diminished oral health-related 
quality of life (4, 6-9). It usually needs high treatment costs, hospitalizations and thus 
constitute a major challenge in public health (6). 
1.1.1.1 Clinical Presentation and Classification 
ECC has a singular characteristic in clinical appearance which is a rapid development of 
caries that affects the teeth soon after they emerge in the oral cavity (10).  
These lesions involve tooth surfaces that are usually less prone to caries development, such 
as the labial surfaces of maxillary incisors and lingual and buccal surfaces of maxillary and 
mandibular molars. ECC initially presents as dull white or brown spots on maxillary 
incisors along the gingival margin, which progresses to an entire destruction of the crown, 
reaching to root stumps (11). Several researchers have developed classification systems for 
early childhood caries (Tables 1.1–1.3). 

























1.1.1.2 Epidemiology  
Despite the decline in the prevalence of dental caries in children, caries in preschool 
children remains a major problem in both developed and developing countries (13). The 
prevalence of ECC varies widely with several factors like race, culture, ethnicity, 
socioeconomic status, lifestyle, dietary pattern, fluoride exposure, and oral hygiene 
practices. In most developed countries, the prevalence rate of ECC is between 1 and 12% 
(14). Prevalence has been reported to be as high as 70% among children with low 
socioeconomic status in less developed countries as well as disadvantaged groups in the 
developed countries (15, 16).  
The national surveys from some countries, such as Sweden (11.4%), Italy (7–19.0%), 
Greece (36%), Brazil (45.8%), India (51.9%), and China (85.5%), showed the inconsistent 
prevalence of ECC (17-20).  
In the U.S., epidemiologic data from a 2011-2012 national survey clearly indicate that ECC 
remains highly prevalent in poor and near poor U.S. preschool children. For the general 
population of preschool children, the prevalence of ECC, as measured by decayed and 
filled tooth surfaces (dfs), is unchanged from previous surveys, but the filled component 
(fs) has greatly increased indicating that more treatment is being provided (21). 
According to a study, the highest prevalence of ECC in children aged between 8 months 
and 7 years is found in the 3- to 4-year-old age group and that boys are significantly more 





1.1.1.3 Etiology of ECC 
Dental caries results from the interaction of cariogenic microorganisms, fermentable 
carbohydrates (substrate), and susceptible tooth surface/host that present concurrently to 
initiate and progress the disease. Other risk factors associated with ECC have also 
documented including low socioeconomic status, minority status, low birth weight, mother 
oral health status, child oral health-care behavior; late commencement of child tooth 
brushing and irregular brushing habits, feeding behavior; night time bottle feeding and 









Figure 1.1: The influence of host–microbe–diet interactions in the etiology and 




1.1.1.3.1 Cariogenic Microorganisms 
• Bacteria: 
The most common microorganisms associated with the initiation of ECC are Streptococcus 
mutans (S. mutans) and Streptococcus sobrinus. Lactobacilli also play an important role in 
the development and progression of caries lesions, but not its initiation (26). S. mutans 
converts fermentable carbohydrates into acids, which contribute to the demineralization of 
tooth structure (27, 28). Preschool children with high levels of S. mutans in the oral cavity 
had a greater risk for new lesions development and higher caries prevalence (29). It has 
been found that children having high S. mutans levels were five times more prone to have 
dental caries (30). S. mutans isolates from infants indicated that these bacteria can be 
transmitted from mother to child via vertical transmission through saliva which is 
considered as the major source of acquiring the S. mutans during the first 12–24 months 
(30-32). Frequent maternal snacking and sugar exposure with poor oral hygiene 
maintenance and sharing food with their children increase the chances of transmission of 
the infection to the child (33). Also, S. mutans can be horizontally transmission between 
siblings (34, 35). The infants delivered by C-section acquire S. mutans earlier than 
vaginally delivered infants since these deliveries are more aseptic and the atypical 
microbial environment increases the chances of S. mutans colonization (36). Other bacteria 
like Actinomyces species, specifically Actinomyces gerencseriae, were also related to 
caries initiation (37), while Bifidobacterium species were related to deep caries lesions 
(37). Few non-mutans streptococci that have acidogenic and aciduric properties were also 




Saliva has a protective feature against dental caries by providing the antimicrobial 
properties, the buffering capacity, and clearance of foods from the mouth that are important 
in reducing the development of caries (40). The low salivary flow rate at night may increase 
the caries risk for infants and toddlers with bedtime bottle feeding (41). 
• Fungi: 
Epidemiological data suggest that C. albicans also plays a significant role in the 
pathogenesis of dental caries. Several clinical studies have shown that C. albicans is 
frequently detected in high numbers in plaque-biofilms from children and toddlers with 
ECC (42-48). A systematic review of the literature published in 2018 revealed that children 
with oral C. albicans had larger than 5 times higher odds of having ECC compared to those 
without C. albicans and the prevalence of C. albicans in children with ECC was 
significantly higher than in children without caries (49).  A similar outcome was reported 
in another study in which the frequency of C. albicans isolated in dental plaque from 
children with ECC was confirmed to be higher than that in caries-free children (44.1 vs. 
19.2 %, χ2  = 22.213, p < 0.001), which indicated that C. albicans is significantly associated 
with ECC (50). 
C. albicans may be transmitted vertically from caregiver to child through salivary contact 
suggesting that the mother might be a source for C. albicans acquisition in the oral cavity 
of children affected by ECC (51). Recent evidence supports that the interactions between 
C. albicans and S. mutans are associated with the pathogenesis of ECC. It has been reported 
that the presence of C. albicans enhances S. mutans growth, and accumulation within 




exposing dentin were observed supporting the synergistic effect of C. albicans and S. 
mutans in amplifying dental caries, (Figure 1.2) (54). 
In vivo, a study using a rodent model and a diet rich in sucrose showed that a high level of 
S. mutans in plaque-biofilms associated with C. albicans co-infection leads to onset of 









Figure 1.2: Images of teeth from rats infected with S. mutans UA159 and/or C. 
albicans SC5314, or left uninfected, after 2 weeks. Black arrows indicate moderate to 





Furthermore, C. albicans appears to activate S. mutans genes associated with biofilm 
formation and genetic competence (56). It has been reported that C. albicans can change 
the gene expression in S. mutans leading to differentially expression of 393 genes that 
increase the carbohydrate utilization and metabolism by S. mutans resulting in a significant 
amount of format in the culture medium of co-cultured biofilms and influences the genes 
transcription of S. mutans that are associated with its virulence and fitness (57). Regarding 
C. albicans’s potential to induce dental caries, researchers have found that the 
acidogenicity and aciduricity are important factors in C. albicans virulence for ECC 
development (48, 58). More importantly, an in vivo study demonstrated the pronounced 
ability of C. albicans to produce acids causing advanced occlusal caries in rats (59). 
1.1.1.3.2 Diet 
Diet contents and dietary practices play a significant role in the development of ECC. High 
consumption of fermentable carbohydrates is a strong risk factor associated with microbial 
etiology of dental caries (59, 60). Also, the inappropriate dietary practice can prolong the 
exposure of the teeth to fermentable carbohydrates that aggravates the ECC. It has been 
found that the frequent nighttime bottle-feeding with milk and ad libitum breastfeeding has 
been associated with ECC in children (61).  The breastfeeding duration was also found to 
be associated with an increased risk for ECC among 2- to 5-year-old children (62). A result 
of a systematic review revealed that breastfeeding for more than a year and at night is 
associated with an increased prevalence of dental caries (63). 
Also, bottle feeding with the juice during bedtime, frequent use of a sippy or no-spill cup, 




increase the risk of caries due to prolonged contact between sugars in the consumed food 
or liquid and cariogenic bacteria on the teeth (64-66). According to the AAP 
recommendations, infants should not be given juice from bottles or covered cups that allow 
them to consume juice throughout the day, and intake of 100 percent fruit juice should be 
limited to no more than four to six ounces per day for children one through six years old 
(67).The caries conducive dietary practices such as frequent exposure to sugar, frequent 
snacking, taking sweetened drinks to bed, sharing foods with adults, and dietary habits 
appear to be established by 12 months of age and are maintained throughout early 
childhood that predisposes to early microorganism colonization and establishment of caries 
(60). 
1.1.1.3.3 Environmental Factors 
According to the AAPD, children should receive oral hygiene care upon the eruption of 
the first primary tooth (68). Lack of good oral hygiene practices and lack of fluoride 
exposure causes the development of ECC (63). The newly erupted teeth of immature 
enamel and teeth with enamel hypoplasia are at higher risk of developing caries (69). 
Studies have shown that the presence of enamel hypoplastic defects was associated with 
prenatal conditions such as premature birth and low birth weight, as well as with 
malnutrition and illness (70-72). Other factors such as caregivers’ social status, poverty, 
ethnicity, deprivation, education, and dental insurance coverage have a significant 
influence on the oral hygiene habits of children and the severity of ECC (22, 73, 74). It has 
been shown that children from low socioeconomic parents are two times more likely to 




1.1.1.4 Management of ECC  
Maintaining a healthy primary dentition is important for the well-being of the child. The 
primary dentition is essential for proper mastication, esthetics, phonetics, space 
maintenance, and prevention of health issues resulting from primary teeth loss (77). ECC 
preventive strategies start with prenatal education of expectant parent(s)/caregiver about 
the etiology, feeding behaviors, and prevention of ECC, progress through the perinatal 
period, and continue with the mother and infant (Figure 1.3) (2). Measures for adequate 
dental treatment and maintenance good oral hygiene should be taken during pregnancy and 
postnatal periods to reduce or delay ECC in infants (78-80). A recent study of the multilevel 
conceptual model suggests that both social and behavioral change is important in the 
prevention of ECC (81).  
Prevention of dental caries in children can be achieved by performing dental plaque control 
measures, changing the bacterial composition of plaque, diet counseling, maintain good 
oral hygiene, and the use of preventive agents like fluorides (82). Fluorides are highly 
effective in preventing dental caries including water fluoridation, fluoridated toothpaste, 
fluoridated mouth rinse, and professional topical fluoride application, by antibacterial 
effect, inhibiting demineralizing and promoting remineralization processes in the affected 
tooth (83).  
According to AAPD, the current best preventive practice to reduce the risk of ECC includes 
twice-daily brushing with fluoridated toothpaste for all children in optimally-fluoridated 
and fluoride-deficient communities by using a smear or rice-sized amount of fluoridated 




toothpaste for children aged three to six dispensed by parents onto a soft, age-appropriate 
sized toothbrush who perform or assist with toothbrushing for preschool-aged children 
(84). 
Professionally applied topical fluoride treatments are also efficacious in reducing the 
prevalence of ECC in children. According to the AAPD, children should receive oral 
hygiene care upon the eruption of the first primary tooth (85). The recommended 
professionally applied fluoride treatment for youngsters in danger of ECC who are younger 
than six years is five percent sodium fluoride varnish (NaFV; 22,500 ppm F) (86). The 
evidence on its effect in preventing dental caries has been reviewed in many narrative 
reviews and systematic reviews/meta-analyses and showed that commercially available 
formulation of sodium fluoride varnish of 5% is the most commonly used topical fluoride 












Untreated decay in children remains clinical and public health challenge in the U.S. and 
worldwide since it confers significant health and quality of life impacts children and their 
parents (89, 90). Restorative work in young children and children with special health care 
needs often requires advanced pharmacologic behavior guidance modalities (e.g., sedation, 
general anesthesia) because of the lack in the ability to cope with the extensive treatment 
procedures, that have additional health risks and limitations, such as possible effects on 
brain development in young children (91), has mortality risks (92), often is not accessible, 
at all or in a timely manner, and costly, especially when hospitalization is required (6, 93, 
94).  
Above noted downsides of traditional restorative treatment call for other alternative 
modalities of caries management. SDF represents as an alternative modality for caries 
treatment by arresting the rate of dental caries as much as 70 percent (i.e., higher than other 
comparable interventions). Besides its efficacy, SDF has been favored based on its less 
invasive (clinically and in terms of behavior guidance requirements) nature, and safety and 
its inexpensiveness (92).  
SDF has been used in Japan for over 40 years and, during the past decade, many other 
countries such as Australia and China have been using it to arrest caries and reduce tooth 
hypersensitivity in primary and permanent teeth (95). Recently, the Food and Drug 
Administration (FDA) approved the dental application of SDF for reducing tooth 
sensitivity, and off-label use of it for arresting caries (96, 97). As marketed in the United 




which is equivalent to five percent fluoride (44,800 ppm F) in a colorless liquid, with a pH 
of 10 (98). The mechanism of SDF belongs to its composition containing silver and fluoride 
that reduce S. mutans levels in oral biofilms (99), while inhibiting the process of 
demineralization by conserving the collagen from degradation (100), and promoting dentin 
remineralization by the interaction of fluoride ions with hydroxyapatite in an alkaline 
environment to form fluorapatite which is less soluble than hydroxyapatite in an acidic 
environment (101, 102)   
Many clinical trials have evaluated the efficacy of SDF on caries arrest and/or prevention 
and consistently concluded that SDF is more effective in arresting caries than fluoride 
varnish (97, 101, 103-105). Upon administration to the tooth surface, SDF retains 
approximately 2-3 times more fluoride than that delivered by sodium fluoride, stannous 
fluoride, or acidulated phosphate fluoride (APF), those of which are commonly found in 
foams, gels, and varnishes (106).  It has been found that the annual application of SDF is 
more effective in arresting caries lesions than the application of five percent sodium 
fluoride varnish four times per year (107). 
It is true that SDF also has some downsides. The major disadvantage of SDF is the dark 
discoloration of carious dentin which is outweighed by its desirable properties in most 
cases, especially when the use of advanced behavioral guidance techniques such as 
sedation or general anesthesia to deliver traditional restorative care is avoided. According 
to AAPD, SDF usage is indicated in a patient with high caries risk who have active 
cavitated caries lesions in anterior or posterior teeth; in a patient who presents with 




patient with multiple cavitated caries lesions that may not all be treated in one visit; in a 
patient with dental caries lesions that are difficult to treat; or in a patient without access to 
or with difficulty accessing dental care (92). However, because of the esthetic concerns, 


















1.2 CURRENT STUDY 
1.2.1 Significance and Innovation 
ECC is a significant dental problem affecting preschool children worldwide. In general, 
80% of the ECC is detected in preschool children from low-income family (44). Untreated 
caries leads to the dental pulp and/or periapical infection, causing inflammation 
accompanied by pain which may, in turn, affect a child’s growth, development and general 
health (89, 90).  
Results from several clinical studies revealed that, in addition to S. mutans infection, C. 
albicans is frequently detected in high numbers in plaque-biofilms from children and 
toddlers with ECC (44-48).  
Traditionally, fluoride varnish is used to prevent ECC in children and adolescent (87, 88, 
109). However, studies have shown that the SDF treatment had a good success rate in 
inhibiting ECC progress in primary teeth (88, 92) and has advantage over fluoride varnish 
in 1) extended in vivo half-life owing to Ammonia added in the solution 2) bactericidal 
effects based on the presence of silver that possesses strong antimicrobial function (88, 
101). 
To the best of our knowledge, no research has ever addressed the inhibitory effect of SDF 
on the growth of C. albicans, representing the scientific merit of this study. Despite the 
drawback of SDF of black staining of caries affected teeth, such a cost-effective approach 
is well-accepted to arrest caries in young and special care needs children. Especially, fewer 




restorative treatment. Therefore, the study of the possible effects of SDF on arresting C. 
albicans-associated ECC may offer a translational significance and explore another 
beneficial mechanism of SDF in arresting ECC to gain a better understanding of the 
mechanism of SDF in arresting the C. albicans-associated ECC, in addition to its known 
mechanisms.  
1.2.2 Specific Aims  
The ultimate goal of this study was to determine whether SDF has an inhibitory effect on 
C. albicans. C. albicans is significantly associated with ECC and might be a risk factor in 
ECC development (110). 
Specific Objectives: 
Specific Aim 1: To describe and compare the inhibitory effects of SDF, fluoride varnish, 
fluconazole (positive control group), and PBS (negative control group) on two 
concentrations of C. albicans (1 × 105/plate or 1 × 106/ plate). 
Specific Aim 2: To determine the minimum inhibitory concentration (MIC) of SDF on the 
growth of C. albicans of 1 × 105/plate. 
1.2.3. Hypothesis  
Hypothesis: There are significant differences in the inhibitory effect of SDF, fluoride 
varnish, fluconazole (positive control group), and PBS (negative control group) on the 
growth of C. albicans. 
Null hypothesis: There are no significant differences in the inhibitory effect of SDF, 
fluoride varnish, fluconazole (positive control group), and PBS (negative control group) 




CHAPTER 2: MATERIALS AND METHODS 
2.1 Part1. Study Plan:  
This study is an in vitro experimental study. It evaluated the antifungal effect of SDF (38%) 
using both disk diffusion assay and minimum inhibitory concentration (MIC) assay which 
are considered gold standards for testing.  
In disk diffusion assay, the antifungal effect of SDF (38%) was evaluated and compared it 
to that of fluoride varnish (5%), fluconazole (25 µg/mL, positive control group) and 
Phosphate Buffered Saline (PBS: negative control group) on two different concentrations 
of C. albicans (1 × 105/plate or 1 × 106/plate).  
The experiment was performed in quadruplicates for each studied group (4 well/group) and 
each experiment was repeated three times as recommended by many studies (111-114) and 
according to Power analysis. 
The number of observations were as follow, Figure 2.1: -  
-For the concentration of C. albicans of 1 × 105/plate, the total number of the wells per 
tested group was 12 and the total number of wells for all groups was 48.  
-For the concentration of C. albicans of 1 × 106/plate, the total number of the wells per 

















Figure 2.1: Study plan of disk diffusion assay, G1=SDF (38%), G2=fluoride varnish (5%), 
G3= fluconazole (25 µg/mL) (positive control group) and G4= Phosphate Buffered Saline 







In MIC assay, the lowest concentration of SDF (38%) and fluconazole (25 µg/mL) 
(positive control group) that inhibited the visible growth of C. albicans of 1 × 105 was 
evaluated. 
Twenty dilutions of each group were performed. For each dilution, 4 wells were used.  
The number of observations were as follow, Figure 2.2: - 
-For fluconazole (25 µg/mL): 20 dilutions, 4 well/dilution. 







            Fluconazole (25 µg/mL)                                                 SDF (38%) 





2.2 Part 2. Instrumentation: 
1) Variables: 
Independent variables:  
The independent variables included SDF (38%) (Advantage arrest, USA. LOT # 19095), 
Sodium fluoride varnish (5%) (FluroDose®, Centrex, USA, LOT # 360087), 
fluconazole (25 µg/mL) (TCI, USA, LOT # EXZCF-KF), Phosphate Buffered Saline 
(PBS), and C. albicans of 1 × 105/plate or 1 × 106/plate concentration (ATCC 10231) 
(Fisher scientific, USA, LOT # 7003147).          
Dependent variables:  
In disk diffusion assay, the dependent variable was the diameter of the zone of growth 
inhibition. More specifically, the diameters of the zone of inhibition (clear zone around 
each well) obtained from four study arms, 1) SDF (38%), 2) fluoride varnish (5%), 3) 
fluconazole (25 µg/mL) and 4) Phosphate Buffered Saline (PBS) on the C. albicans (1 
× 105/plate or 1 × 106/plate) grown on the agar plates were measured in millimeter using 
a digital caliper (Neiko, USA). 
In MIC assay, the dependent variable was the lowest concentration of two test reagents, 
1) SDF (serial dilutions of starting concentration of 38%), and 2) fluconazole (serial 
dilutions of starting concentration of 25 µg/mL) that show at least 90% growth inhibition 





2) Reliability and Validity:  
The inhibitory effects of SDF on growth of C albicans was evaluated using both disk 
diffusion assay and MIC assay. 
-MIC assay is the gold standard and the reference technique of antifungal susceptibility 
test. Its method is standardized by various organizations, such as the Clinical and 
Laboratory Standards Institute (CLSI), the International Organization for Standardization 
(ISO) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST). It 
is used to define the lowest concentration of an antimicrobial that will inhibit the visible 
growth of a microorganism after overnight incubation (115). It is considered as a reliable 
and standardized method for diagnostic purposes and used as a guide for the clinician to 
the susceptibility of the organism to the antimicrobial agent and aids in treatment decisions 
(116).  
-Disk diffusion assay is one of the most commonly used antifungal susceptibility 
comparison tests to evaluate the antifungal effects of reagents of interest. It is well accepted 
to be simple, rapid, and cost-effective experiment, producing highly reproducible results 
and correlate well with the MIC method, making agar-based method a viable alternative to 
MIC assay for C. albicans susceptibility testing. The essential and strong agreements of 
the results of disk diffusion assay to that of MIC assay for testing the susceptibility against 
Candida is higher than 94%, rendering the disk diffusion assay as a valid screening 
technique for testing the susceptibility of C. albicans strains (117-119).  
-Intra and interexaminer reliability of the measurement of the diameter of the inhibition 
zone using digital caliper is conducted after receiving a professional training from Dr. 




inhibition zone in both intra and interexamination. 
2.3 Part 3. Design and Procedure:  
1) Research design:  This research is an in vitro experimental-complete randomized block-
design. 
2) Study Groups and Procedures:  
In disk diffusion assay, there were four tested groups as shown in Table 2.1. 
Table 2.1: The tested groups and their roles: 
 
The experiment was conducted in a laminar flow hood (Air Science® FLOW-36 Purair® 
FLOW) and the prepared agar plates were incubated at 36 ± 1⁰C in the aerobic condition 
in an incubator (VWR, USA) according to the methods for antifungal disk diffusion 
susceptibility testing guideline (120), and as shown in Figure 2.3. 
a) Preparation of the suspensions of C. albicans: C. albicans cultured in Sabouraud 
Dextrose Broth (SDB, Difco Laboratories) at mid log growth phase (OD600 = 0.8-
1.0) was harvested, and suspended in 2 mL of sterile Phosphate Buffered Saline 
(PBS) to yield an inoculum (1 × 105 or 1 × 106 colony-forming units (CFU)/50 
μL) based on optical density (OD) at 600 nm (conversion factor: 1 U at OD600 is 
Group 1 SDF (38%) Experimental group 
Group 2 fluoride varnish (5%) Experimental group 
Group 3 fluconazole (25 µg/mL) Positive control group 




equal to approximately 3 × 107 CFU/mL). OD600 was measured using a plate 
reader (Synergy H1, BioTek). 
 
b) Preparation of growth plate:  Fifty µL of suspension containing 105 or 106 
CFU/mL of C. albicans was plated onto Mueller-Hinton agar Mueller Hinton Agar 
(Prepared Media Plates 150 x 15 mm, Corolina, USA), evenly spread with the 
bacterial cell spreader (VWR, USA) over the entire agar surface. This procedure 
was repeated by streaking two more times, rotating the plate approximately 60° 
each time to ensure an even distribution of inoculum. 
c) Preparation of the tested materials: As a positive control antifungal agent, 
fluconazole (TCI, USA) was employed. Distilled water was used as a solvent for 
fluconazole. The stock solution of 1280 𝜇g/mL was prepared. Then, the final 
concentration of 25 𝜇g/mL was prepared using the equation of: 
       C1V1=C2V2 ……………………………………………………(1) 
             C1 = Initial concentration of solution 
          V1 = Initial volume of solution 
          C2 = Final concentration of solution 
          V2 = Final volume of solution 
 
The surface of Mueller-Hinton agar in a plastic Petri dish was divided into 4 equal 
quadrants. In each quadrant, a paper disk filter (Whatman® Antibiotic Assay Discs, 6 
mm Ø, Sigma Aldrich) was placed at equal distance. Then, 20 µL of the test solutions 





d) Incubation: Plates were incubated at 36 ± 1⁰C for 24 hrs in the aerobic condition 
in an incubator. After 24 hrs of incubation, the zone of inhibition was measured. 
e) Measuring the diameter of the zone of inhibition: The diameter of the zone of 
inhibition (clear zone around each well) was measured with a digital caliper in 
















In MIC assay, serially diluted SDF and fluconazole (positive control group) were reacted 
to suspension of C. albicans at the concentration below the detectable range by a plate 
reader. 
To avoid the contamination of airborne bacteria, the preparation of MIC assay was 
conducted in a laminar flow hood according to the method of MIC testing guideline (121) 
and as shown in Figure 2.4. 
Twenty serial dilutions of SDF (starting conc. at 38%) and fluconazole (starting conc. at 
25 µg/mL) in distilled water were prepared in a 96-well plate (VWR, USA). For each 
dilution, 4 wells were used (quadruplicate). Then, 10 µL of serially diluted SDF or 
fluconazole was applied to C. albicans (1×105 cells/mL) suspended in Sabouraud Dextrose 
broth (90 µL/well).  
The plate was incubated at 36 ± 1⁰C for 24 hrs in the aerobic condition. After 24 hrs of 










2.4   Part 4. Power Analysis 
A power analysis was performed using the guidelines provided in Sample Size Choice by 
Odeh, R.E. and Fox, M. (122) and Pass 16 software (NCSS, LLC) functionality. Table 2.2 
shows the power analysis for a Randomized Block Analysis of Variance displaying the 
stipulated conditions. 
 
Table 2.2: Randomized Block Analysis of Variance 
Numeric Results                                                                                                                                                               
      Standard Block-  
   Number    Deviation Treatment Effect 
  of    of Means Interaction Size 
Term Power Blocks Units df1 df2 (σm) (σ) (σm/σ)
 Alpha Beta 
A 0.6604 4 12 2 6 1.000 1.000 1.000
 0.05 0.34 
Definitions of terms used: 
Power is the probability of rejecting a false null hypothesis. 
Blocks are the number of plated in the design. 
Units are the number of experimental units in the design. 
df1 is the numerator degrees of freedom. 
df2 is the denominator degrees of freedom. 
σm is the standard deviation of the group means or effects. 
σ is the pooled block-treatment interaction. 
Effect Size is the ratio σm/σ 
Alpha is the probability of rejecting a true null hypothesis. 





A randomized-block design with one treatment factor at 4 levels has 4.0 blocks each with 
4.0 treatment combinations. The square root of the block-treatment interaction is 1.000. 
This design achieves 77% power when an F test is used to test factor A at a 5% significance 
level and the actual standard deviation among the appropriate means is 1.000 (an effect 
size of 1.000). 
2.5   Part 5. Statistical Analysis  
For the analysis of results from disk diffusion assay: Univariate statistics was calculated 
for all study variables. Results were expressed as a mean ± SD. Statistical analysis was 
done using a statistical package, R 3.4.2. The susceptibility of the studied groups (control 
groups and experimental groups) was compared using Randomized Block Analysis of 
Variance test followed by the Tukey’s HSD test for multiple comparisons. An alpha of.05 
was employed to test the null hypothesis. 
For the analysis of MIC assay: Results were expressed as a mean ± SD. The minimum 
inhibitory concentration results were expressed as a percentage (wt/vol %) of respective 









CHAPTER 3: RESULTS 
3.1 Disk Diffusion Assay  
The diameter of inhibition zone (clear zone around each well) of SDF (38%), fluoride 
varnish (5%), fluconazole (25 µg/mL), PBS on C. albicans of 1 × 105/plate or  1 × 106/plate 
concentration was measured in millimeter with a digital caliper. The concentrations of SDF 
and fluoride varnish were employed from those used in dental practice.  
For C. albicans of 1 × 105/plate, the diameter of inhibition zone of SDF and fluconazole 
(positive control group) was 26.60 ± 0.64 mm and 17.25 ± 1.50 mm, respectively. No 
visible inhibition zone for fluoride varnish or PBS (negative control group) was detected, 
as shown in Figure 3.1, and Table 3.1. 
A one-way ANOVA was conducted to see if the diameter of inhibition zone is statistically 
different among SDF, fluoride varnish, fluconazole (positive control group), and PBS 
(negative control group). The results showed that there is a statistically significant 
difference in the diameter of inhibition among SDF, fluconazole, fluoride varnish and PBS 
on the C. albicans grown at the concentration of 1 × 105/plate, F(3,44) = 3089.64, p < .001, 
as shown in Table 3.2. 
Tukey test was conducted to detect the significant difference between each two groups. 
The results showed that there was a statistically significant between 1) SDF and 
fluconazole, 2) SDF and fluoride varnish or PBS, 3) fluconazole and fluoride varnish or 
PBS, p < .001. There was no significant difference between fluoride varnish and PBS 













Figure 3.1: The inhibition zone of SDF, fluoride varnish, fluconazole (positive control 










Table 3.1: The diameter of inhibition zone (mm) of SDF, fluoride varnish, fluconazole 
(positive control group), and PBS (negative control group) for C. albicans concentration 




Table 3.2: One-Way ANOVA of the diameter of inhibition zone (mm) of SDF, fluoride 
varnish, fluconazole (positive control group), and PBS (negative control group) for C. 
albicans concentration of 1 × 105/plate, * means significant difference. 
Source DF Sum of Squares Mean Square F Ratio P-value 
Group 3 6242.06 2098.68 3089.64 0.000* 
Error 44 29.63 0.67   




             Groups                                        Diameter of inhibition zone (mm) 
                                                                 for C. albicans conc. of 1 × 105/plate 
 N Average SD Min Max 
 SDF (38%) 12 26.60 0.64 25.43 27.62 
Fluoride varnish (5%) 12  0.10 0.00  0.10  0.10 
Fluconazole (25 µg/mL) 12 17.25 1.50 15.77 18.74 




Table 3.3: Tukey test of the difference of the diameter of inhibition zone (mm) of SDF, 
fluoride varnish, fluconazole (positive control group), and PBS (negative control group) 
for C. albicans concentration of 1 × 105/plate, * means significant difference. 
 
  
Groups Difference Lower 95% CI Upper 95% CI p-Value 
1 vs 2 26.50417 25.6097 27.39868 0.000*  
1 vs 4 26.50417 25.7097 27.49868 0.000*  
3 vs 2 17.15000 16.2555 18.04451 0.000*  
3 vs 4 17.15000 16.2555 18.04451 0.000*  
1 vs 3 9.35417 8.4597 10.24868 0.000*  



















   
Figure 3.2: Comparisons of the difference of the inhibition zone (mm) of SDF to that of 
fluoride varnish, fluconazole (positive control group), and PBS (negative control group) 











For C. albicans applied at the concentration of 1 × 106/plate, the diameter of the inhibition 
zone of SDF and fluconazole (positive control group) was 25.68 ± 1.06 mm and 16.05 ± 
1.61 mm, respectively. No visible inhibition zone for fluoride varnish or PBS (negative 
control group) was detected, as shown in Figure 3.3, and Table 3.4. 
A one-way ANOVA was conducted to see if the diameter of inhibition zone is statistically 
different among SDF, fluoride varnish, fluconazole (positive control group), and PBS 
(negative control group). The results showed that there is a statistically significant 
difference in the diameter of inhibition zone among SDF, fluconazole, fluoride varnish and 
PBS on the C. albicans grown at concentration of 1 × 106/plate, F(3,44) = 2035.37, p < 
.001, as shown in Table 3.5. 
Tukey test was conducted to detect the significant difference between each two groups, the 
results showed that there was a statistically significant difference between 1) SDF and 
fluconazole, 2) SDF and fluoride varnish or PBS, 3) fluconazole and fluoride varnish or 
PBS, p < .001. There was no significant difference between fluoride varnish and PBS 














Figure 3.3: The inhibition zone of SDF, fluoride varnish, fluconazole (positive control 









Table 3.4: The diameter of inhibition zone (mm) of SDF, fluoride varnish, fluconazole 
(positive control group), and PBS (negative control group) for C. albicans concentration 
of 1 × 106/plate. 
 
 
Table 3.5: One-Way ANOVA of the diameter of inhibition zone (mm) of SDF, fluoride 
varnish, fluconazole (positive control group), and PBS (negative control group) for C. 
albicans concentration of 1 × 106/plate, * means significant difference. 
Source DF Sum of Squares Mean 
Square 
F Ratio P-value 
Groups 3 5733.88 1911.29 2035.37  0.000* 
Error 44 41.31 0.94   




             Groups                                             Diameter of inhibition zone (mm) 
                                                                      for C. albicans conc. of 1 × 106/plate 
 N Average SD Min Max 
 SDF (38%) 12 25.68 1.06 23.66 27.20 
Fluoride varnish (5%) 12  0.10 0.00  0.10  0.10 
Fluconazole (25 µg/mL) 12 16.05 1.61 13.14 18.82 




Table 3.6: Tukey test of the difference of diameter of inhibition zone (mm) of SDF, 
fluoride varnish, fluconazole (positive group), and PBS (negative group) for C. albicans 
concentration of 1 × 106/plate, * means significant difference. 
 
  
Groups Difference Lower 95% CI Upper 95% CI p-Value 
1 vs 2 25.58583 24.5296 26.64211 0.000* 
1 vs 4 25.58583 24.5296 26.64211 0.000* 
3 vs 2 15.95833 14.9021 17.01461 0.000* 
3 vs 4 15.95833 14.9021 17.01461 0.000* 
1 vs 3 9.62750 8.5712 10.68378 0.000* 





















Figure 3.4: Comparing the difference of the diameter of inhibition zone (mm) of SDF to 
that of fluoride varnish, fluconazole (positive control group), and PBS (negative control 


















C. albicans conc. of 1 × 105/plate C. albicans conc. of 1 × 106/plate
A t-test was conducted to see if the diameter of inhibition zone of SDF is different on C. 
albicans concentrations of 1 × 105/plate and 1 × 106/plate, the result showed that there is 
no significant difference between the diameter of inhibition zone of SDF on both C. 
albicans concentrations of 1 × 105/plate and 1 × 106/plate, t( 18.11) = 2.105, p = .161, 
despite the diameter of inhibition zone by SDF on C. albicans of 1 × 105/plate (Mean = 
26.60, SD = 0.64) was more than that on C. albicans of 1 × 106/plate (Mean = 25.68, SD = 









Figure 3.5: Comparing the diameter of inhibition zone of SDF on C. albicans of 1 × 






3.2 MIC Assay  
In MIC assay, the antifungal effect of the serial dilutions of SDF (starting conc. 38%) and 
fluconazole (starting conc. 25 µg/mL) was compared. The MIC of SDF was 0.009% of its 
original concentration, while the MIC of fluconazole was 0.6% of its original concentration 


















































3.3   SUMMARY of FINDINGS: 
1) There is a statistically significant difference in the diameter of inhibition zone between 
1) SDF and fluconazole, 2) SDF and fluoride varnish or PBS, 3) fluconazole and fluoride 
varnish or PBS on the C. albicans grown at the concentration of 1 × 105/plate. 
2) There is a statistically significant difference in the diameter of inhibition zone between 
1) SDF and fluconazole, 2) SDF and fluoride varnish or PBS, 3) fluconazole and fluoride 
varnish or PBS on the C. albicans grown at the concentration of 1 × 106/plate. 
3) There is no significant difference between the diameter of inhibition zone of SDF on 
both C. albicans concentrations of 1 × 105/plate and 1 × 106/plate. 
4) The MIC of SDF was 0.009% of its original concentration, while the MIC of fluconazole 










CHAPTER 4: DISCUSSION 
The treatment of ECC is often expensive, requiring extensive restorative procedure and/or 
extraction of teeth at an early age with a demand of sedation or general anesthesia at times 
due to the lack of the ability to cope with the extensive treatment procedures in young 
children (82). SDF is considered as a cost-effective therapeutic agent for dental caries 
reduction in preschool children and in children with special care needs. It has a good 
success rate in preventing the progress of ECC by inhibiting the process of 
demineralization, conserving the collagen from degradation, enhancing dentin 
remineralization, and reducing S. mutans levels in oral biofilms (94). 
S. mutans is considered as the major pathogen in ECC. However, C. albicans has been 
implicated as one of the major contributing factors for the high prevalence of ECC. 
Therefore, the purpose of this study was to evaluate the possible inhibitory effect of SDF 
on the growth of C. albicans that would further explain the success of SDF in arresting 
ECC.  
4.1 Disk Diffusion Assay 
The results using disk diffusion method showed that SDF had a significant inhibitory effect 
on the growth of C. albicans, even more than fluconazole (positive control group), and 5% 
fluoride varnish. Fluoride varnish did not exhibit any inhibitory effect on the growth of C. 
albicans.  
SDF contains approximately 24-28 percent (weight/volume) silver and 5-6 percent fluoride 




attributed to the silver content of SDF. Silver compounds have a long history of use in both 
medicine and dentistry because of their antimicrobial properties. It has been reported that 
silver particles suppressed the growth of various pathogenic fungi such as Candida, 
Aspergillus, and Cryptococcus species (123, 124), and even the antifungal drug-resistant 
C. albicans was inhibited by silver particles (125).  
Treating C. albicans with silver for 24 hours lead to suppress C. albicans biofilm formation 
and disrupt the structural layers of the outer fungal cell wall (126, 127).  
It has been concluded that the multitargeted action of silver including generation of 
intracellular reactive oxygen species (ROS), alterations in ergosterol content, and 
membrane fluidity together seem to have potentiated anti-Candida action (128). Also, the 
combination of silver with 3-bromopyruvate enhanced cell death in C. albicans (129). 
Furthermore, it was revealed that silver affected multiple process vital for pathogenesis of 
C. albicans and pivotal for its virulence and biofilm formation including alteration of 
surface morphology, cellular ultrastructure, membrane microenvironment, membrane 
fluidity, ergosterol content, and fatty acid composition, especially oleic acid (130). 
On the other hand, it was reported that the fungicidal capacity of silver, after the exposure 
time of 24 h, came from the aggregation of silver particles outside the fungal cells, releasing 
silver ions and inducing cell death through the reduction process resulting from the 
interaction of cell wall and cytoplasm with ionic silver (131). 
Kim et al., showed that the activity of silver against C. albicans was found to be 
comparable to that of amphotericin B, but superior to that of fluconazole (126), which 




growth is more than that of fluconazole since SDF contains silver in its composition. To 
our knowledge, no study done before to investigate the inhibitory effect of SDF on the 
growth of C. albicans to compare our results to it. 
Also, the result of the comparison between the diameter of inhibition zone of SDF on both 
C. albicans concentrations of 1 × 105/plate and 1 × 106/plate showed no significant 
difference between them. That means even when the concentration of C. albicans elevated 
by 10 times, SDF still exhibited an inhibitory effect on the growth of C. albicans and there 
was no significant difference in the diameter of inhibition zone of SDF on both 
concentrations of C. albicans. 
In this study’s results, 5% sodium fluoride varnish did not exhibit any antifungal effect on 
the growth of C. albicans. This result is consistent with the result of a study done to 
compare the antifungal effect of commonly used fluorides which were 5% fluoride varnish, 
and amine fluoride/stannous fluoride combination (AmF/SnF2) comparing their antifungal 
effect to that of chlorhexidine (positive control group) using MIC. It has been found that 
the inhibitory effect on the growth of C. albicans of AmF / SnF2 was comparable with that 
of chlorhexidine, whereas 5% fluoride varnish had the weakest effect (132).  
Also, other study comparing the inhibitory effect of several commercial mouthwashes with 
various, active ingredients of fluoride (FLO), cethylpyridinium chloride (CPC), 
chlorhexidine gluconate (CHX), triclosan (TRI) and herbal extracts: Twin Lotus (TLO) 
and Herbric concentrated (HBC) on C. albicans  activities included growth, germ tube 
formation and adhesion to human buccal mucosa. It was reported that TRI, TLO and CHX 




mouthwashes had ability to inhibit adhesion of C. albicans. CHX, TRI and CPC 
mouthwashes had ability to suppress germ tube formation, and mycelial conversion of C. 
albicans. However, fluoride mouthwash showed the weakest in all inhibitory activities 
(133).  
It can be concluded that the antifungal effect of SDF belongs to its silver content since the 
fluoride component in fluoride varnish did not show any inhibitory effect on the growth of 
C. albicans. In clinical studies, it has been illustrated that SDF is more efficient than 
fluoride varnish in arresting ECC because of its composition of high concentration of silver 
and fluoride. It was reported that SDF was more effective in arresting dentin caries in 
primary anterior teeth in pre-school children than 5% fluoride varnish (104, 106, 134). 
Also, it has been found that annual application of SDF was more effective in arresting 
caries lesions than application of five percent sodium fluoride varnish four times per year 
(107). 
4.2 MIC Assay 
In this study, MIC assay was used to determine the minimum SDF concentration that can 
inhibit the growth of C. albicans. MIC assay is considered as the gold standard and a 
reference technique of antifungal susceptibility test that used to define the lowest 
concentration of an antimicrobial that will inhibit the visible growth of a microorganism 
after overnight incubation (115). The result showed that the MIC of SDF was 0.009% of 
its original concentration, which means SDF can inhibit the growth of C. albicans at lower 
concentration than antifungal effect mediated by fluconazole, making the effect of saliva 
dilution to minimum after clinical application. For our knowledge, no study of SDF’s MIC 




CHAPTER 5: CONCLUSIONS 
This study, for the first time, demonstrated the inhibitory effect of SDF on the growth of 
C. albicans, indicating that SDF possesses sufficiently efficient antifungal property as 
determined by the significantly lesser MIC of SDF to suppress the growth of C. albicans 
compared to fluconazole.  This study gained a mechanistic insight into the microbiological 
impact of SDF in arresting the C. albicans-associated ECC and discovered a new beneficial 
antifungal efficacy of SDF, in addition to its known mechanisms in preventing the growth 
of S. mutans and inhibition of dentin demineralization.  This finding is expected to lead to 















Recommendations for future studies 
• To study the effect of SDF in vivo using animal models. 
• To study the inhibitory effect of SDF on a combination of C. albicans and S. mutans. 




The results of this study have been presented in REACH Day at Nova Southeastern 
University in February 21, 2020 and was judged as Outstanding by the Research 
Committee. Also, it has been presented in AAPD annual meeting at Nashville, TN in May 
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